• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Sabra Reports First Quarter 2024 Results; Reiterates 2024 Guidance

    5/8/24 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate
    Get the next $SBRA alert in real time by email

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2024.

    FIRST QUARTER 2024 RESULTS AND RECENT EVENTS

    • Results per diluted common share for the first quarter of 2024 were as follows:
      • Net Income: $0.11
      • FFO: $0.32
      • Normalized FFO: $0.34
      • AFFO: $0.35
      • Normalized AFFO: $0.35
    • EBITDARM Coverage Summary:
      • Skilled Nursing/Transitional Care: 1.79x (1.79x excluding Provider Relief Funds)
      • Senior Housing - Leased: 1.33x
      • Behavioral Health, Specialty Hospitals and Other: 3.77x
    • On May 8, 2024, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on May 31, 2024, to common stockholders of record as of the close of business on May 20, 2024.

    2024 GUIDANCE

    Sabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):

    • Net Income: $0.53 - $0.57
    • FFO: $1.33 - $1.37
    • Normalized FFO: $1.34 - $1.38
    • AFFO: $1.38 - $1.42
    • Normalized AFFO: $1.39 - $1.43

    Earnings guidance above assumes no 2024 acquisition or disposition activity.

    Commenting on the first quarter's results, Rick Matros, CEO and Chair, said, "As has been evident for several quarters, Sabra's portfolio continues to grow stronger, whether looking at coverage, occupancy, or NOI. Trailing-twelve-month SNF coverage saw a healthy 0.06x increase sequentially, to 1.79x, when excluding the impact of Provider Relief Funds. Our SHOP portfolio continues to improve, and this quarter's results - which faced a challenging year-over-year comp - are in line with our expectations embedded in guidance. Our balance sheet remains strong and is poised to support future growth.

    Although we have no new investments to discuss this quarter, the pipeline has improved and with what we are working on, we expect to announce new investments on our second quarter call."

    LIQUIDITY

    As of March 31, 2024, we had approximately $913.8 million of liquidity, consisting of unrestricted cash and cash equivalents of $59.9 million and available borrowings of $853.9 million under our revolving credit facility. As of March 31, 2024, we also had $500.0 million available under the ATM program.

    CONFERENCE CALL AND COMPANY INFORMATION

    A conference call with a simultaneous webcast to discuss the 2024 first quarter results will be held on Thursday, May 9, 2024, at 10:00 am Pacific Time. The webcast URL is https://events.q4inc.com/attendee/588244325. The dial-in number for U.S. participants is (888) 880-4448. For participants outside the U.S., the dial-in number is (646) 960-0572. The conference ID number is 1382596. A digital replay of the call will be available on the Company's website at www.sabrahealth.com. The Company's supplemental information package for the first quarter will also be available on the Company's website in the "Investors" section.

    ABOUT SABRA

    As of March 31, 2024, Sabra's investment portfolio included 374 real estate properties held for investment (consisting of (i) 237 Skilled Nursing/Transitional Care facilities, (ii) 38 senior housing communities ("Senior Housing - Leased"), (iii) 66 senior housing communities operated by third-party property managers pursuant to property management agreements ("Senior Housing - Managed"), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), four assets held for sale, 14 investments in loans receivable (consisting of two mortgage loans and 12 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of March 31, 2024, Sabra's real estate properties held for investment included 37,750 beds/units, spread across the United States and Canada.

    FORWARD-LOOKING STATEMENTS SAFE HARBOR

    This release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identified, without limitation, by the use of "expects," "believes," "intends," "should" or comparable terms or the negative thereof. Examples of forward-looking statements include all statements regarding our expectations regarding earnings growth; and our other expectations regarding our future financial position (including our earnings guidance for 2024, as well as the assumptions set forth therein), results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments and dispositions, and plans and objectives for future operations and capital raising activity.

    Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including, among others, the following: increased labor costs and historically low unemployment; increases in market interest rates and inflation; pandemics or epidemics, including COVID-19, and the related impact on our tenants, borrowers and Senior Housing - Managed communities; operational risks with respect to our Senior Housing - Managed communities; competitive conditions in our industry; the loss of key management personnel; uninsured or underinsured losses affecting our properties; potential impairment charges and adjustments related to the accounting of our assets; the potential variability of our reported rental and related revenues as a result of Accounting Standards Update ("ASU") 2016-02, Leases, as amended by subsequent ASUs; risks associated with our investment in our unconsolidated joint ventures; catastrophic weather and other natural or man-made disasters, the effects of climate change on our properties and a failure to implement sustainable and energy-efficient measures; increased operating costs and competition for our tenants, borrowers and Senior Housing - Managed communities; increased healthcare regulation and enforcement; our tenants' dependency on reimbursement from governmental and other third-party payor programs; the effect of our tenants, operators or borrowers declaring bankruptcy or becoming insolvent; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; the impact of litigation and rising insurance costs on the business of our tenants; the impact of required regulatory approvals of transfers of healthcare properties; environmental compliance costs and liabilities associated with real estate properties we own; our tenants', borrowers' or operators' failure to adhere to applicable privacy and data security laws, or a material breach of our or our tenants', borrowers' or operators' information technology; our concentration in the healthcare property sector, particularly in skilled nursing/transitional care facilities and senior housing communities, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; adverse changes in our credit ratings; our ability to make dividend distributions at expected levels; our ability to raise capital through equity and debt financings; changes and uncertainty in macroeconomic conditions and disruptions in the financial markets; risks associated with our ownership of property outside the U.S., including currency fluctuations; the relatively illiquid nature of real estate investments; our ability to maintain our status as a real estate investment trust ("REIT") under the federal tax laws; compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; changes in tax laws and regulations affecting REITs; the ownership limits and takeover defenses in our governing documents and under Maryland law, which may restrict change of control or business combination opportunities; and the exclusive forum provisions in our bylaws.

    Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the "SEC"), including in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, unless required by law to do so.

    TENANT AND BORROWER INFORMATION

    This release includes information regarding certain of our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. The information related to our tenants and borrowers that is provided in this release has been provided by, or derived from information provided by, such tenants and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only.

    NOTE REGARDING NON-GAAP FINANCIAL MEASURES

    This release includes the following financial measures defined as non-GAAP financial measures by the SEC: funds from operations ("FFO"), Normalized FFO, Adjusted FFO ("AFFO"), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share, Normalized AFFO per diluted common share and net operating income ("NOI"). These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under "Reporting Definitions" in this release, and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included on the Investors section of our website at https://ir.sabrahealth.com/investors/financials/quarterly-results.

     

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED STATEMENTS OF INCOME (LOSS)

    (dollars in thousands, except per share data)

     

     

    Three Months Ended March 31,

     

     

    2024

     

     

     

    2023

     

    Revenues:

     

     

     

    Rental and related revenues (1)

    $

    91,776

     

     

    $

    95,870

     

    Resident fees and services

     

    66,031

     

     

     

    56,721

     

    Interest and other income

     

    8,940

     

     

     

    8,733

     

    Total revenues

     

    166,747

     

     

     

    161,324

     

    Expenses:

     

     

     

    Depreciation and amortization

     

    42,914

     

     

     

    52,827

     

    Interest

     

    28,408

     

     

     

    28,540

     

    Triple-net portfolio operating expenses

     

    4,324

     

     

     

    4,168

     

    Senior housing - managed portfolio operating expenses

     

    49,669

     

     

     

    43,637

     

    General and administrative

     

    11,890

     

     

     

    10,502

     

    Recovery of loan losses

     

    (137

    )

     

     

    (208

    )

    Impairment of real estate

     

    3,137

     

     

     

    7,064

     

    Total expenses

     

    140,205

     

     

     

    146,530

     

    Other income (expense):

     

     

     

    Loss on extinguishment of debt

     

    —

     

     

     

    (1,541

    )

    Other income

     

    760

     

     

     

    341

     

    Net loss on sales of real estate

     

    —

     

     

     

    (21,515

    )

    Total other income (expense)

     

    760

     

     

     

    (22,715

    )

     

     

     

     

    Income (loss) before loss from unconsolidated joint ventures and income tax expense

     

    27,302

     

     

     

    (7,921

    )

    Loss from unconsolidated joint ventures

     

    (595

    )

     

     

    (838

    )

    Income tax expense

     

    (453

    )

     

     

    (728

    )

    Net income (loss)

    $

    26,254

     

     

    $

    (9,487

    )

     

     

     

     

    Net income (loss), per:

     

     

     

    Basic common share

    $

    0.11

     

     

    $

    (0.04

    )

    Diluted common share

    $

    0.11

     

     

    $

    (0.04

    )

     

     

     

     

    Weighted average number of common shares outstanding, basic

     

    231,453,564

     

     

     

    231,164,876

     

    Weighted average number of common shares outstanding, diluted

     

    233,365,031

     

     

     

    231,164,876

     

    (1)

    See next table for additional details regarding Rental and related revenues.

     

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED STATEMENTS OF INCOME (LOSS) - SUPPLEMENTAL INFORMATION

    (in thousands)

     

     

    Three Months Ended March 31,

     

     

    2024

     

     

     

    2023

     

    Cash rental income

    $

    89,036

     

     

    $

    89,657

     

    Straight-line rental income

     

    1,152

     

     

     

    1,347

     

    Write-offs of cash and straight-line rental income receivable and lease intangibles

     

    (2,954

    )

     

     

    (518

    )

    Above/below market lease amortization

     

    1,211

     

     

     

    1,568

     

    Operating expense recoveries

     

    3,331

     

     

     

    3,816

     

    Rental and related revenues

    $

    91,776

     

     

    $

    95,870

     

     

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED BALANCE SHEETS

    (dollars in thousands, except per share data)

     

     

    March 31, 2024

     

    December 31, 2023

    Assets

     

     

     

    Real estate investments, net of accumulated depreciation of $1,059,405 and $1,021,086 as of March 31, 2024 and December 31, 2023, respectively

    $

    4,577,318

     

     

    $

    4,617,261

     

    Loans receivable and other investments, net

     

    422,472

     

     

     

    420,624

     

    Investment in unconsolidated joint ventures

     

    132,022

     

     

     

    136,843

     

    Cash and cash equivalents

     

    59,927

     

     

     

    41,285

     

    Restricted cash

     

    6,003

     

     

     

    5,434

     

    Lease intangible assets, net

     

    28,301

     

     

     

    30,897

     

    Accounts receivable, prepaid expenses and other assets, net

     

    148,395

     

     

     

    133,806

     

    Total assets

    $

    5,374,438

     

     

    $

    5,386,150

     

     

     

     

     

    Liabilities

     

     

     

    Secured debt, net

    $

    46,810

     

     

    $

    47,301

     

    Revolving credit facility

     

    146,127

     

     

     

    94,429

     

    Term loans, net

     

    534,993

     

     

     

    537,120

     

    Senior unsecured notes, net

     

    1,735,455

     

     

     

    1,735,253

     

    Accounts payable and accrued liabilities

     

    112,764

     

     

     

    136,981

     

    Lease intangible liabilities, net

     

    31,115

     

     

     

    32,532

     

    Total liabilities

     

    2,607,264

     

     

     

    2,583,616

     

    Equity

     

     

     

    Preferred stock, $0.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2024 and December 31, 2023

     

    —

     

     

     

    —

     

    Common stock, $0.01 par value; 500,000,000 shares authorized, 231,494,286 and 231,266,020 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively

     

    2,315

     

     

     

    2,313

     

    Additional paid-in capital

     

    4,495,663

     

     

     

    4,494,755

     

    Cumulative distributions in excess of net income

     

    (1,761,999

    )

     

     

    (1,718,279

    )

    Accumulated other comprehensive income

     

    31,195

     

     

     

    23,745

     

    Total equity

     

    2,767,174

     

     

     

    2,802,534

     

    Total liabilities and equity

    $

    5,374,438

     

     

    $

    5,386,150

     

     

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands)

     

     

    Three Months Ended March 31,

     

     

    2024

     

     

     

    2023

     

    Cash flows from operating activities:

     

     

     

    Net income (loss)

    $

    26,254

     

     

    $

    (9,487

    )

    Adjustments to reconcile net income (loss) to net cash provided by operating activities:

     

     

     

    Depreciation and amortization

     

    42,914

     

     

     

    52,827

     

    Non-cash rental and related revenues

     

    591

     

     

     

    (2,398

    )

    Non-cash interest income

     

    7

     

     

     

    (392

    )

    Non-cash interest expense

     

    3,071

     

     

     

    3,014

     

    Stock-based compensation expense

     

    2,521

     

     

     

    2,229

     

    Loss on extinguishment of debt

     

    —

     

     

     

    1,541

     

    Recovery of loan losses

     

    (137

    )

     

     

    (208

    )

    Net loss on sales of real estate

     

    —

     

     

     

    21,515

     

    Impairment of real estate

     

    3,137

     

     

     

    7,064

     

    Loss from unconsolidated joint ventures

     

    595

     

     

     

    838

     

    Distributions of earnings from unconsolidated joint ventures

     

    1,478

     

     

     

    367

     

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable, prepaid expenses and other assets, net

     

    (6,288

    )

     

     

    (2,782

    )

    Accounts payable and accrued liabilities

     

    (21,348

    )

     

     

    (5,839

    )

    Net cash provided by operating activities

     

    52,795

     

     

     

    68,289

     

    Cash flows from investing activities:

     

     

     

    Acquisition of real estate

     

    —

     

     

     

    (39,630

    )

    Origination and fundings of loans receivable

     

    (102

    )

     

     

    (1,800

    )

    Origination and fundings of preferred equity investments

     

    (1,007

    )

     

     

    (6,384

    )

    Additions to real estate

     

    (12,935

    )

     

     

    (19,540

    )

    Repayments of loans receivable

     

    391

     

     

     

    6,144

     

    Repayments of preferred equity investments

     

    617

     

     

     

    1,433

     

    Investment in unconsolidated joint ventures

     

    (188

    )

     

     

    (4,797

    )

    Net proceeds from the sales of real estate

     

    —

     

     

     

    152,259

     

    Net proceeds from sales-type lease

     

    —

     

     

     

    25,490

     

    Net cash (used in) provided by investing activities

     

    (13,224

    )

     

     

    113,175

     

    Cash flows from financing activities:

     

     

     

    Net borrowings from (repayments of) revolving credit facility

     

    52,404

     

     

     

    (118,442

    )

    Proceeds from term loans

     

    —

     

     

     

    12,186

     

    Principal payments on secured debt

     

    (503

    )

     

     

    (490

    )

    Payments of deferred financing costs

     

    (80

    )

     

     

    (18,127

    )

    Issuance of common stock, net

     

    (2,606

    )

     

     

    (1,847

    )

    Dividends paid on common stock

     

    (69,444

    )

     

     

    (69,351

    )

    Net cash used in financing activities

     

    (20,229

    )

     

     

    (196,071

    )

    Net increase (decrease) in cash, cash equivalents and restricted cash

     

    19,342

     

     

     

    (14,607

    )

    Effect of foreign currency translation on cash, cash equivalents and restricted cash

     

    (131

    )

     

     

    (641

    )

    Cash, cash equivalents and restricted cash, beginning of period

     

    46,719

     

     

     

    53,932

     

    Cash, cash equivalents and restricted cash, end of period

    $

    65,930

     

     

    $

    38,684

     

    Supplemental disclosure of cash flow information:

     

     

     

    Interest paid

    $

    20,495

     

     

    $

    22,318

     

    Supplemental disclosure of non-cash investing activities:

     

     

     

    Decrease in loans receivable and other investments due to acquisition of real estate

    $

    —

     

     

    $

    4,644

     

     

    SABRA HEALTH CARE REIT, INC.

    FUNDS FROM OPERATIONS (FFO), NORMALIZED FFO,

    ADJUSTED FUNDS FROM OPERATIONS (AFFO) AND NORMALIZED AFFO

    (dollars in thousands, except per share data)

     

     

    Three Months Ended March 31,

     

     

    2024

     

     

     

    2023

     

    Net income (loss)

    $

    26,254

     

     

    $

    (9,487

    )

    Add:

     

     

     

    Depreciation and amortization of real estate assets

     

    42,914

     

     

     

    52,827

     

    Depreciation, amortization and impairment of real estate assets related to unconsolidated joint ventures

     

    2,229

     

     

     

    2,048

     

    Net loss on sales of real estate

     

    —

     

     

     

    21,515

     

    Impairment of real estate

     

    3,137

     

     

     

    7,064

     

    FFO

    $

    74,534

     

     

    $

    73,967

     

    Write-offs of cash and straight-line rental income receivable and lease intangibles

     

    2,921

     

     

     

    540

     

    Loss on extinguishment of debt

     

    —

     

     

     

    1,541

     

    Recovery of loan losses

     

    (137

    )

     

     

    (208

    )

    Other normalizing items (1)

     

    1,121

     

     

     

    1,037

     

    Normalized FFO

    $

    78,439

     

     

    $

    76,877

     

    FFO

    $

    74,534

     

     

    $

    73,967

     

    Stock-based compensation expense

     

    2,521

     

     

     

    2,229

     

    Non-cash rental and related revenues

     

    591

     

     

     

    (2,398

    )

    Non-cash interest income

     

    7

     

     

     

    (392

    )

    Non-cash interest expense

     

    3,071

     

     

     

    3,014

     

    Non-cash portion of loss on extinguishment of debt

     

    —

     

     

     

    1,541

     

    Recovery of loan losses

     

    (137

    )

     

     

    (208

    )

    Other adjustments related to unconsolidated joint ventures

     

    153

     

     

     

    69

     

    Other adjustments

     

    410

     

     

     

    403

     

    AFFO

    $

    81,150

     

     

    $

    78,225

     

    Other normalizing items (1)

     

    1,106

     

     

     

    1,021

     

    Normalized AFFO

    $

    82,256

     

     

    $

    79,246

     

    Amounts per diluted common share:

     

     

     

    Net income (loss)

    $

    0.11

     

     

    $

    (0.04

    )

    FFO

    $

    0.32

     

     

    $

    0.32

     

    Normalized FFO

    $

    0.34

     

     

    $

    0.33

     

    AFFO

    $

    0.35

     

     

    $

    0.34

     

    Normalized AFFO

    $

    0.35

     

     

    $

    0.34

     

    Weighted average number of common shares outstanding, diluted:

     

     

    Net income (loss)

     

    233,365,031

     

     

     

    231,164,876

     

    FFO and Normalized FFO

     

    233,365,031

     

     

     

    231,892,769

     

    AFFO and Normalized AFFO

    234,671,379

    233,168,932

    (1)

    Other normalizing items for FFO and AFFO primarily include triple-net operating expenses, net of recoveries.

    Behavioral Health

    Includes behavioral hospitals that provide inpatient and outpatient care for patients with mental health conditions, chemical dependence or substance addictions and addiction treatment centers that provide treatment services for chemical dependence and substance addictions, which may include inpatient care, outpatient care, medical detoxification, therapy and counseling.

    EBITDARM

    Earnings before interest, taxes, depreciation, amortization, rent and management fees ("EBITDARM") for a particular facility accruing to the operator/tenant of the property (not the Company), for the period presented. The Company uses EBITDARM in determining EBITDARM Coverage. EBITDARM has limitations as an analytical tool. EBITDARM does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDARM does not represent a property's net income or cash flows from operations and should not be considered an alternative to those indicators. The Company utilizes EBITDARM to evaluate the core operations of the properties by eliminating management fees, which may vary by operator/tenant and operating structure, and as a supplemental measure of the ability of the Company's operators/tenants and relevant guarantors to generate sufficient liquidity to meet related obligations to the Company.

    EBITDARM Coverage

    Represents the ratio of EBITDARM to cash rent for owned facilities (excluding Senior Housing - Managed communities) for the period presented. EBITDARM Coverage is a supplemental measure of a property's ability to generate cash flows for the operator/tenant (not the Company) to meet the operator's/tenant's related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDARM. EBITDARM Coverage includes only Stabilized Facilities and excludes facilities for which data is not available or meaningful.

    Funds From Operations ("FFO") and Adjusted Funds from Operations ("AFFO")*

    The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company also believes that funds from operations, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts ("Nareit"), and adjusted funds from operations, or AFFO (and related per share amounts) are important non-GAAP supplemental measures of the Company's operating performance. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, Nareit created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP. FFO is defined as net income, computed in accordance with GAAP, excluding gains or losses from real estate dispositions and the Company's share of gains or losses from real estate dispositions related to its unconsolidated joint ventures, plus real estate depreciation and amortization, net of amounts related to noncontrolling interests, plus the Company's share of depreciation and amortization related to its unconsolidated joint ventures, and real estate impairment charges of both consolidated and unconsolidated entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity. AFFO is defined as FFO excluding stock-based compensation expense, non-cash rental and related revenues, non-cash interest income, non-cash interest expense, non-cash portion of loss on extinguishment of debt, provision for (recovery of) loan losses and other reserves, non-cash lease termination income and deferred income taxes, as well as other non-cash revenue and expense items (including noncapitalizable acquisition costs, transaction costs related to operator transitions and organizational or other restructuring activities, ineffectiveness gain/loss on derivative instruments, and non-cash revenue and expense amounts related to noncontrolling interests) and the Company's share of non-cash adjustments related to its unconsolidated joint ventures. The Company believes that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of the Company's operating results among investors and makes comparisons of operating results among real estate investment trusts more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed above, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of real estate investment trusts, they do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company's liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company's real estate assets nor do they purport to be indicative of cash available to fund the Company's future cash requirements. Further, the Company's computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define AFFO differently than the Company does.

    Net Operating Income ("NOI")*

    The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines NOI as total revenues less operating expenses. NOI excludes all other financial statement amounts included in net income.

    Normalized FFO and Normalized AFFO*

    Normalized FFO and Normalized AFFO represent FFO and AFFO, respectively, adjusted for certain income and expense items that the Company does not believe are indicative of its ongoing operating results. The Company considers Normalized FFO and Normalized AFFO to be useful measures to evaluate the Company's operating results excluding these income and expense items to help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and Normalized AFFO do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company's liquidity or operating performance. Normalized FFO and Normalized AFFO also do not consider the costs associated with capital expenditures related to the Company's real estate assets nor do they purport to be indicative of cash available to fund the Company's future cash requirements. Further, the Company's computation of Normalized FFO and Normalized AFFO may not be comparable to Normalized FFO and Normalized AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define FFO and AFFO or Normalized FFO and Normalized AFFO differently than the Company does.

    Senior Housing

    Senior Housing communities include independent living, assisted living, continuing care retirement and memory care communities.

    Senior Housing - Managed

    Senior Housing communities operated by third-party property managers pursuant to property management agreements.

    Skilled Nursing/Transitional Care

    Skilled Nursing/Transitional Care facilities include skilled nursing, transitional care, multi-license designation and mental health facilities.

    Specialty Hospitals and Other

    Includes acute care, long-term acute care and rehabilitation hospitals, facilities that provide residential services, which may include assistance with activities of daily living, and other facilities not classified as Skilled Nursing/Transitional Care, Senior Housing or Behavioral Health.

    Stabilized Facility

    At the time of acquisition, the Company classifies each facility as either stabilized or non-stabilized. In addition, the Company may classify a facility as non-stabilized after acquisition. Circumstances that could result in a facility being classified as non-stabilized include newly completed developments, facilities undergoing major renovations or additions, facilities being repositioned or transitioned to new operators, and significant transitions within the tenants' business model. Such facilities are typically reclassified to stabilized upon the earlier of maintaining consistent performance or 24 months after the date of classification as non-stabilized. Stabilized Facilities generally exclude (i) facilities held for sale, (ii) strategic disposition candidates, (iii) facilities being transitioned to a new operator, (iv) facilities being transitioned from being leased by the Company to being operated by the Company and (v) leased facilities acquired during the three months preceding the period presented.

    *Non-GAAP Financial Measures

    Reconciliations, definitions and important discussions regarding the usefulness and limitations of the Non-GAAP Financial Measures used in this release can be found at https://ir.sabrahealth.com/investors/financials/quarterly-results.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240508078469/en/

    Get the next $SBRA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SBRA

    DatePrice TargetRatingAnalyst
    1/17/2025Buy → Hold
    Truist
    1/7/2025$20.00Mkt Perform → Mkt Outperform
    JMP Securities
    12/5/2024$20.00Outperform → Neutral
    Mizuho
    10/1/2024$16.00 → $20.00Equal Weight → Overweight
    Wells Fargo
    9/13/2024$17.00 → $20.00Neutral → Buy
    Citigroup
    1/30/2024$21.00Buy
    Deutsche Bank
    10/17/2023$16.00Outperform → Market Perform
    BMO Capital Markets
    10/16/2023$13.00 → $15.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $SBRA
    SEC Filings

    See more
    • SEC Form 144 filed by Sabra Health Care REIT Inc.

      144 - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      5/15/25 4:10:13 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by Sabra Health Care REIT Inc.

      10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:06:34 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:05:31 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Financials

    Live finance-specific insights

    See more
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Behavioral Health, Specialty Hospitals and Other: 3.66x Same store managed senior housing Cash NOI increased 17.9% on a year-over-year basis. As previously announced, in the fourth quarter of 2024, Sabra cl

      2/19/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cusack Catherine bought $40,315 worth of shares (2,500 units at $16.13), increasing direct ownership by 4% to 60,583 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      2/25/25 5:04:04 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Cusack Catherine bought $101,010 worth of shares (7,000 units at $14.43), increasing direct ownership by 18% to 46,385 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/23/24 7:00:45 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sabra Health Care REIT, Inc. to Participate in Nareit's REITweek 2025 Investor Conference and Attend ASHA's 2025 Mid-Year Meeting

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2025 Investor Conference June 2 – 5, 2025 at the New York Hilton Midtown in New York, New York. Additionally, Talya Nevo-Hacohen, Darrin Smith, and other members of the company, will attend ASHA's 2025 Mid-Year Meeting on June 9 – 10, 2025, at the Omni Interlocken Hotel, in Broom

      5/22/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sabra Health Care REIT Inc.

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      10/18/24 11:35:05 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 5:13:53 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 2:19:42 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sabra Health Care REIT downgraded by Truist

      Truist downgraded Sabra Health Care REIT from Buy to Hold

      1/17/25 11:05:39 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT upgraded by JMP Securities with a new price target

      JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00

      1/7/25 8:27:55 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT downgraded by Mizuho with a new price target

      Mizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00

      12/5/24 8:19:25 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Foster Michael J sold $200,376 worth of shares (11,000 units at $18.22), decreasing direct ownership by 15% to 64,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/22/25 2:55:39 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Porter Clifton J Ii was granted 855 shares, increasing direct ownership by 2% to 48,721 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:49:21 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Malehorn Jeffrey A. was granted 946 shares, increasing direct ownership by 1.00% to 95,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:48:55 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Leadership Updates

    Live Leadership Updates

    See more
    • Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer

      Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit

      1/4/24 9:15:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Katie Cusack to its Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided

      1/12/21 9:05:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Ann Kono to Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M

      12/21/20 9:00:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate